Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Takeda Pharmaceutical Co Ltd    4502   JP3463000004

TAKEDA PHARMACEUTICAL CO LTD (4502)
My previous session
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Financials (JPY)
Sales 2019 1 766 B
EBIT 2019 -
Net income 2019 155 B
Debt 2019 680 B
Yield 2019 3,84%
Sales 2020 1 818 B
EBIT 2020 -
Net income 2020 209 B
Debt 2020 541 B
Yield 2020 3,84%
P/E ratio 2019 22,38
P/E ratio 2020 18,65
EV / Sales2019 2,49x
EV / Sales2020 2,35x
Capitalization 3 723 B
More Financials
Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs.It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.The Prescription Drugs segment includes the manufacture... 
More about the company
Surperformance© ratings of Takeda Pharmaceutical Co L
Trading Rating : Investor Rating :
More Ratings
Latest news on TAKEDA PHARMACEUTICAL CO L
09/18TAKEDA PHARMACEUTICAL : receives clearance from the State Administration for Mar..
AQ
09/18TAKEDA PHARMACEUTICAL : Selected by the Dow Jones Sustainability Asia Pacific In..
PU
09/15TAKEDA PHARMACEUTICAL : Shire gains as takeover approved by China
AQ
09/14SHIRE : Takeda Moving U.S. Headquarters From Chicago Area to Boston
AQ
09/14Takeda gets China's approval for $62 billion Shire purchase
RE
09/14TAKEDA PHARMACEUTICAL : receives clearance from the State Administration for Mar..
PU
09/13TAKEDA PHARMACEUTICAL : "Sustained-Release Formulation" in Patent Application Ap..
AQ
09/13TAKEDA PHARMACEUTICAL : Findings in Medicinal Chemistry Reported from Takeda Pha..
AQ
09/13TAKEDA WEIGHS SALE OF SHIRE'S EYE CA : Bloomberg
RE
09/13TAKEDA PHARMACEUTICAL : weighs sale of Shire's eye care business to cut debt - B..
RE
More news
Sector news : Pharmaceuticals - NEC
04:10aBAYER : Steps Up Legal Fight Over Weed Killer Blamed for Cancer
DJ
09/18ABBVIE : California Insurance Commissioner Sues AbbVie, Alleging 'Kickbacks' for..
DJ
09/18COCA COLA : buys Australia's kombucha maker Mojo
RE
09/18GLAXOSMITHKLINE : GSK grabs new drug development head from Boehringer
RE
09/18Aurora Cannabis Says No Current Deal on Partnership With Beverage Company
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
09/17Barclays : Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD  
09/14Takeda Pharmaceutical Co Ltd - Takeda Receives Clearance From State Administr..
3
09/13Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt: Takeda Pharmaceut..
1
09/12Shire : Form 8.3 - Takeda Pharmaceutical Company Limited  
09/12Barclays : Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD  
More tweets
Qtime:53
News from SeekingAlpha
09/14Carolinas Brace For Hurricane Florence (Wall Street Breakfast Podcast) 
09/14WALL STREET BREAKFAST : Carolinas Brace For Hurricane Florence 
09/14Takeda gets Shire clearance from China 
09/11Merger Arbitrage In One Place (Part 2) 
09/05Abivax UC candidate shows positive action in mid-stage study 
Chart TAKEDA PHARMACEUTICAL CO LTD
Duration : Period :
Takeda Pharmaceutical Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TAKEDA PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 6 361  JPY
Spread / Average Target 36%
EPS Revisions
Managers
NameTitle
Christophe Weber President, CEO & Representative Director
Costa Saroukos Chief Financial Officer
Andrew S. Plump Director, Chief Medical & Scientific Officer
Yasuhiko Yamanaka Managing Director & Head-Globalization
Masato Iwasaki Director & President-Japan Pharma Business Unit
Sector and Competitors
1st jan.Capitalization (M$)
TAKEDA PHARMACEUTICAL CO LTD-27.12%33 237
JOHNSON & JOHNSON0.59%375 479
PFIZER18.75%252 129
NOVARTIS-1.14%215 800
ROCHE HOLDING LTD.-4.00%212 015
MERCK AND COMPANY25.15%187 284